Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (14) , 1967-1969
- https://doi.org/10.1097/00002030-200209270-00017
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Prevalence and Predictive Value of Intermittent Viremia With Combination HIV TherapyJAMA, 2001
- Antiretroviral resistance during successful therapy of HIV type 1 infectionProceedings of the National Academy of Sciences, 2000
- Time of initiation of antiretroviral therapy: impact on HIV-1 viraemiaAIDS, 2000
- The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapyNature Medicine, 2000
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- Comparative Performance of High-Density Oligonucleotide Sequencing and Dideoxynucleotide Sequencing of HIV Type 1polfrom Clinical SamplesAIDS Research and Human Retroviruses, 1998
- The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirAIDS, 1998
- Detection of Low HIV-1 RNA Levels in PlasmaJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1996